Millennium Home Care Llc | |
1500 Kings Highway, Port Charlotte, Florida 33980 | |
(855) 674-7500 | |
Name | Millennium Home Care Llc |
---|---|
Location | 1500 Kings Highway, Port Charlotte, Florida |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 109401 |
Ownership Type | Proprietary |
Service Area Zip Codes | 33901, 33903, 33904, 33905, 33907, 33908, 33909, 33912, 33913, 33914, 33916, 33917, 33919, 33920, 33922, 33924, 33928, 33931, 33936, 33946, 33947, 33948, 33950, 33951, 33952, 33953, 33954, 33955, 33956, 33957, 33966, 33967, 33971, 33972, 33973, 33974, 33976, 33980, 33981, 33982, 33983, 33990, 33991, 33993, 34101, 34102, 34103, 34104, 34105, 34108, 34109, 34110, 34112, 34113, 34114, 34116, 34117, 34119, 34120, 34134, 34135, 34140, 34142, 34145, 34223, 34224, 34229, 34266, 34268, 34269, 34275, 34285, 34286, 34287, 34288, 34289, 34291, 34292, 34293 |
NPI Number | 1700058583 |
Organization Name | MILLENNIUM HOME CARE LLC |
Address | 1500 Kings Highway, Port Charlotte, FL 33980 |
Phone Number | 855-674-7500 |
News Archive
Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma (MM). The VELCADE based combinations evaluated in the study demonstrated two-year overall survival rates ranging between 81 and 88 percent.
The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.
During the winter of 2009-2010 the average temperature for the UK was 1.6 degrees centigrade, making it the coldest recorded winter in the last 30 years. Using winter data from 2005 to 2010, new research published in BioMed Central's open access journal Environmental Health demonstrates an inverse relationship between temperature and the number of falls on snow and ice, which result in emergency admission to hospital, and looks at the cost of these falls.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
› Verified 5 days ago
Quality Rating: |
News Archive
Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma (MM). The VELCADE based combinations evaluated in the study demonstrated two-year overall survival rates ranging between 81 and 88 percent.
The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.
During the winter of 2009-2010 the average temperature for the UK was 1.6 degrees centigrade, making it the coldest recorded winter in the last 30 years. Using winter data from 2005 to 2010, new research published in BioMed Central's open access journal Environmental Health demonstrates an inverse relationship between temperature and the number of falls on snow and ice, which result in emergency admission to hospital, and looks at the cost of these falls.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
› Verified 5 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.8 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.7 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 99.9 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 80.2 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 87.3 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.3 | 96.4 |
News Archive
Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma (MM). The VELCADE based combinations evaluated in the study demonstrated two-year overall survival rates ranging between 81 and 88 percent.
The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.
During the winter of 2009-2010 the average temperature for the UK was 1.6 degrees centigrade, making it the coldest recorded winter in the last 30 years. Using winter data from 2005 to 2010, new research published in BioMed Central's open access journal Environmental Health demonstrates an inverse relationship between temperature and the number of falls on snow and ice, which result in emergency admission to hospital, and looks at the cost of these falls.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
› Verified 5 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 78.6 | 79.6 |
How often patients got better at getting in and out of bed | 85.9 | 81.1 |
How often patients got better at bathing | 85.3 | 82.3 |
How often patients’ breathing improved | 88.3 | 82.8 |
How often patients’ wounds improved or healed after an operation | 89 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 80.6 | 75 |
How often home health patients had to be admitted to the hospital | 13 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.2 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 99.7 | 94 |
News Archive
Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma (MM). The VELCADE based combinations evaluated in the study demonstrated two-year overall survival rates ranging between 81 and 88 percent.
The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.
During the winter of 2009-2010 the average temperature for the UK was 1.6 degrees centigrade, making it the coldest recorded winter in the last 30 years. Using winter data from 2005 to 2010, new research published in BioMed Central's open access journal Environmental Health demonstrates an inverse relationship between temperature and the number of falls on snow and ice, which result in emergency admission to hospital, and looks at the cost of these falls.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
› Verified 5 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma (MM). The VELCADE based combinations evaluated in the study demonstrated two-year overall survival rates ranging between 81 and 88 percent.
The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.
During the winter of 2009-2010 the average temperature for the UK was 1.6 degrees centigrade, making it the coldest recorded winter in the last 30 years. Using winter data from 2005 to 2010, new research published in BioMed Central's open access journal Environmental Health demonstrates an inverse relationship between temperature and the number of falls on snow and ice, which result in emergency admission to hospital, and looks at the cost of these falls.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
› Verified 5 days ago
The patient survey data of Millennium Home Care Llc is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
Percent of patients who reported that their home health team communicated well with them | 84 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 86 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 76 | 78 |
News Archive
Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma (MM). The VELCADE based combinations evaluated in the study demonstrated two-year overall survival rates ranging between 81 and 88 percent.
The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.
During the winter of 2009-2010 the average temperature for the UK was 1.6 degrees centigrade, making it the coldest recorded winter in the last 30 years. Using winter data from 2005 to 2010, new research published in BioMed Central's open access journal Environmental Health demonstrates an inverse relationship between temperature and the number of falls on snow and ice, which result in emergency admission to hospital, and looks at the cost of these falls.
Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.
› Verified 5 days ago
Mederi Caretenders Location: 18501 Murdock Circle Suite 602, Port Charlotte, Florida 33948 Ratings: Phone: (941) 379-0801 | |
Kindred At Home Location: 970 Kings Highway Ste 2, Port Charlotte, Florida 33980 Ratings: Phone: (239) 277-1003 | |
Sunrise Home Health & Supplies Llc Location: 22110 Kimble Ave, Port Charlotte, Florida 33952 Ratings: Phone: (941) 235-1722 | |
Amedisys Home Health Location: 4161 Tamiami Trl Bldg 8 Unit 801 A, Port Charlotte, Florida 33952 Ratings: Phone: (941) 629-1600 | |
Signature Homenow Location: 3417 Tamiami Trail Suite A, Port Charlotte, Florida 33952 Ratings: Phone: (941) 629-1212 | |
Millennium Home Care Llc Location: 1500 Kings Highway, Port Charlotte, Florida 33980 Ratings: Phone: (855) 674-7500 |